New Generations Vaccine Adjuvants

Vaccine adjuvants were first reported about 80 years ago and have been utilized to improve immune responses against non-living vaccines since then. Adjuvants are included in vaccines to improve immune responses to vaccine antigens. Viral infectious diseases represent a major portion of global public health concerns with thousands of demise annually. Adjuvants are immune potentiators administered concurrently with antigens in order to increase the vaccine effectiveness. These new-generation vaccine adjuvants massively work by activating the local innate immune system to trigger the antigen-specific immune response. The necessity for vaccine adjuvants was established after the discovery of safe, highly purified, but less immunogenic, synthetic antigens via innovation in recombinant DNA technology.

    Related Conference of New Generations Vaccine Adjuvants

    October 30-31, 2020

    32nd Annual Congress on Immunology and Vaccinations

    Vancouver, Canada

    New Generations Vaccine Adjuvants Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in